NICE chief: Approval changes 'won't increase NHS drugs bill'
The head of the National Institute of Health and Care Excellence has suggested the NHS will not pay more overall for branded pharmaceuticals in future as a result of proposed changes to the way the organisation assesses the value of new drugs.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here